Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Search Results

Your search returned 1870 record(s).

Page 147 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:

  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1461 7.9 months Metastatic renal cell carcinoma 2 Biologic therapy
University of Oxford United Kingdom 11/2004
Treatment Details: Patients: This Phase II trial involved 25 patients with metastatic renal cell carcinoma, 17 men and 8 women. The median age was 62. Fifteen had undergone prior nephrectomy. Treatment: T
1462 7.9 months Hepatocellular carcinoma 4 Biologic therapy
National Institute of Cancer Research Taiwan Region 1/2011
Treatment Details: Patients: In this study, patients with hepatocellular carcinoma were divided into 2 treatment groups. Group A included 18 patients, 83.3% were male and 72.2% were under the age of 70. In
1463 7.9 months NSCLC 4 Biologic therapy
Princess Margaret Hospital Canada 9/2009
Treatment Details: Patients: This phase 2 study involved 18 patients with non-small-cell lung cancer (NSCLC) who had received prior chemotherapy. The median age of the group was 53 years and 50% of the patie
1464 7.8 months Platinum resistant ovarian cancer 4 Chemotherapy
Mount Vernon Cancer Centre United Kingdom 3/2011
Treatment Details: Patients: This phase 2 trial involved women with ovarian cancer that had progressed following prior platinum-based chemotherapy. Patients were divided into two treatment groups. Group A c
1465 7.8 months Advanced colorectal cancer 4 Chemotherapy
The First AYliated Hospital China 1/2011
Treatment Details: Patients: This study involved 57 advanced colorectal cancer patients who had previously been treated with oxaliplatin and fluoropyrimidine. Patients had a median age of 52 years and 58% we
1466 7.8 months Recurrent GBM 4 Chemotherapy
National Cancer Institute United States 5/2011
Treatment Details: Patients: This phase II study involved 40 patients with recurrent glioblastoma who had received prior treatment. The median patient age was 55 years and 75% were male. Treatment: Patie
1467 7.8 months Advanced or metastatic colorectal cancer 4 Biologic therapy
Norris Comprehensive Cancer Center (USC) United States 5/2008
Treatment Details: Patients: This phase II study involved 102 patients with advanced or metastatic colorectal cancer. These patients ranged in age from 31 to 83 years of age; the median age was 60.5 years. T
1468 7.8 months Advanced NSCLC 4 Chemotherapy
University General Hospital of Heraklion Greece 10/2005
Treatment Details: Patients: This Phase II study involved 139 patients with advanced non-small-cell lung cancer. All patients were treated previously with taxanes and gemcitabine. The patients were randomize
1469 7.8 months metastatic melanoma 4 Immunotherapy
Aarhus University Hospital Denmark 12/2002
Treatment Details: Patients: This Phase II study involved 41 patients with metastatic melanoma. The median age was 56. Treatment: The treatment consisted of the drug histamine dihydrochloride and two immun
1470 7.7 months Recurrent GBM 3 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 1/2002
Treatment Details: Twenty-eight patients had recurrent glioblastoma multiforme and seven patients had various types of recurrent anaplastic glioma. All patients had resection at diagnosis and all but one pati
Page 147 of 187  | Previous Page  | Next Page